SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000880771-17-000120
Filing Date
2017-07-03
Accepted
2017-07-03 16:02:17
Documents
1
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4.html 4  
1 PRIMARY DOCUMENT certent-form4.xml 4 12925
  Complete submission text file 0000880771-17-000120.txt   14300
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404
Business Address
Blobel Friedhelm (Reporting) CIK: 0001363213 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 17945454